Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17182820> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q17182820 subject Q6762709.
- Q17182820 subject Q7050887.
- Q17182820 abstract "CytoSorbents is a critical –care focused publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, highly porous polymer beads that act like sponges to remove harmful substances from the blood.CytoSorb, the Company's first product to market, received its CE mark approval in 2011. The product is currently used in Europe for critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. CytoSorbents is the vertically integrated ISO 13485 certified manufacturer of CytoSorb.CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency (DARPA) for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins. The US Army awarded the Company a $1.15 million small-business innovation research contract to evaluate the technology in burn and trauma. The US Air Force is funding a $3million FDA approved randomized controlled trial in trauma and rhabdomyolysis.".
- Q17182820 country Q30.
- Q17182820 numberOfEmployees "52".
- Q17182820 wikiPageWikiLink Q1085950.
- Q17182820 wikiPageWikiLink Q1408.
- Q17182820 wikiPageWikiLink Q1527888.
- Q17182820 wikiPageWikiLink Q170518.
- Q17182820 wikiPageWikiLink Q183134.
- Q17182820 wikiPageWikiLink Q193078.
- Q17182820 wikiPageWikiLink Q6762709.
- Q17182820 wikiPageWikiLink Q7050887.
- Q17182820 wikiPageWikiLink Q864426.
- Q17182820 wikiPageWikiLink Q917069.
- Q17182820 name "Cytosorbents Corporation".
- Q17182820 numEmployees "52".
- Q17182820 type Organization.
- Q17182820 type Agent.
- Q17182820 type Company.
- Q17182820 type Organisation.
- Q17182820 type Agent.
- Q17182820 type SocialPerson.
- Q17182820 type Thing.
- Q17182820 type Q43229.
- Q17182820 comment "CytoSorbents is a critical –care focused publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, highly porous polymer beads that act like sponges to remove harmful substances from the blood.CytoSorb, the Company's first product to market, received its CE mark approval in 2011.".
- Q17182820 label "Cytosorbents".
- Q17182820 name "Cytosorbents Corporation".